SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-021911
Filing Date
2016-08-01
Accepted
2016-08-01 16:37:24
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cemp-10q_20160630.htm 10-Q 1062708
2 EX-31.1 cemp-ex311_6.htm EX-31.1 16921
3 EX-31.2 cemp-ex312_10.htm EX-31.2 16854
4 EX-32.1 cemp-ex321_7.htm EX-32.1 6159
5 EX-32.2 cemp-ex322_9.htm EX-32.2 6081
  Complete submission text file 0001564590-16-021911.txt   3669009

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cemp-20160630.xml EX-101.INS 594707
7 XBRL TAXONOMY EXTENSION SCHEMA cemp-20160630.xsd EX-101.SCH 36883
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cemp-20160630_cal.xml EX-101.CAL 25093
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cemp-20160630_def.xml EX-101.DEF 101749
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemp-20160630_lab.xml EX-101.LAB 287042
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemp-20160630_pre.xml EX-101.PRE 196202
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 161797746
SIC: 2834 Pharmaceutical Preparations